15 Aug 2024 --- A clinical trial finds that OmeGo, Hofseth BioCare’s enzymatically liberated salmon oil, has the potential to improve immune responses and reduce inflammation in people with mild to moderate COVID-19 infection, caused by the SARS-CoV-2 virus. Study participants taking OmeGo had significantly lower levels of pro-inflammatory cytokines, signaling proteins that help control inflammation. These cells are vital to reducing the acute inflammatory response linked to complications of COVID-19. Supplementation with the oil also led to better interferon-related gene expression, which the researchers note is essential for effective viral clearance and maintaining a balanced immune response.
